Respiri’s Healthcare Programs Slash Hospital Visits and Boost Revenue

Respiri Limited (AU:RSH) has released an update.

Respiri Limited has announced significant achievements in healthcare management, including a 56% decrease in hospital re-admissions and a 47% drop in emergency room visits, thanks to its patient programs. This success has led to increased revenues per patient per month and expansion of client services, notably with New York Cancer & Blood which plans to increase patient enrollment from 190 to 1,500, promising an additional US$1.2M in annual revenue. The company’s partnership with the University of Alabama Hospital is also set to expand, demonstrating the economic and health benefits of Respiri’s services.

For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.